Vaccine stands for a preparation of dead, attenuate or else modified viruses, bacteria and other microorganisms utilized as an inoculation to immunize against any disease by way of stimulating antibodies’ production. With constant technology upgrades and launches of new medicinal products, Vaccines proved to be the most sophisticated healthcare aid ever created in the pharma’s history.
The global Vaccine Industry is thriving mainly owing to the chronic availability of different diseases, both already-existing and cropping up on the horizon, which can be luckily prevented with Vaccines’ assistance. Pediatric Vaccines form the largest and the most hastily evolving segment as against adult Vaccines, with the trend predicted to stay unaltered in the impending period. The worldwide Vaccine Market is primarily in the paws of such behemoths as Merck & Company, Inc.; Novartis, Pfizer, Inc.; GlaxoSmithKline plc; and Sanofi Pasteur.
The research reports under this Catalogue provide in-depth assessments of the global Vaccine Industry, discussing pressing market issues and statistical figures. The research reports cover the sizing (value/volume) and short-to-long-run forecasts for the overall Vaccine Market and its major segments, and for numerous geographic markets. The listing of M&As among the Vaccine universe participants with new products’ reviews, alongside company profile information can be derived from the research reports too.
Publications found:
866
Sort by:
Global Anti Rabies Serum Market Growth 2025-2031
US$ 3,660.00
The global Anti Rabies Serum market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Anti-rabies serum is a biological...
September 2025
112 pages
Global Antitetanus Serum Market Growth 2025-2031
US$ 3,660.00
The global Antitetanus Serum market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for Antiteta...
September 2025
111 pages
Global HPV Quadrivalent Vaccine Market Growth 2025-2031
US$ 3,660.00
The global HPV Quadrivalent Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. HPV Quadrivalent Vaccine i...
September 2025
79 pages
Dengue Vaccine Market Forecasts to 2032 – Global Analysis By Product (Dengvaxia, Qdenga, and Other Pipeline Candidates), Vaccine Type, Treatment Adjuncts, Route of Administration, Distribution Channel, End User, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dengue Vaccine Market is accounted for $489.61 million in 2025 and is expected to reach $1358.91 million by 2032 growing at a CAGR of 15.7% during the forecast...
September 2025
200 pages
Measles, Mumps, Rubella (MMR) Vaccines Market Forecasts to 2032 – Global Analysis By Product (M-M-R II, PRIORIX, Tresivac, M-M-RvaxPro, and Other Product Types), Vaccine Type, Route of Administration, Age Group, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Measles, Mumps, Rubella (MMR) Vaccines Market is accounted for $5.73 billion in 2025 and is expected to reach $13.83 billion by 2032 growing at a CAGR of 13.4%...
September 2025
200 pages
Autogenous Vaccines Market - 2024-2033
US$ 2,999.00
The Autogenous Vaccines Market was valued at US$ 141.57Million in 2024 and is anticipated to reach US$ 228.66Million by 2033, at a CAGR of 0.0551 from 2026 to 2032. The report delivers in-depth insigh...
September 2025
219 pages
Dengue Vaccine Market Size, Share & Trends Analysis Report By Product (Dengvaxia, Qdenga), By End-user (Government & Public Health Agencies, Hospitals & Specialty Clinics), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Dengue Vaccine Market The global dengue vaccine market size was estimated at USD 423.18 million in 2024 and is projected to reach USD 1,618.61 million by 2033, growing at a CAGR of 13.73% from 2025 to...
September 2025
150 pages
India Vaccine Market Size, Share & Trends Analysis Report By Indication (Viral Vaccines, Bacterial Vaccines, Cancer Vaccines), By Type, By Route Of Administration (Oral, Parenteral, Nasal), By Age Group, By Distribution Channel, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
India Vaccine Market Size & Trends The India vaccine market was estimated at USD 2.45 billion in 2024 and is projected to reach USD 5.20 billion by 2033, growing at a CAGR of 8.50% from 2025 to 2033....
September 2025
150 pages
India Human Papillomavirus Vaccine Market By Valence (Bivalent, Quadrivalent, Nonvalent, and Others), By Disease Indication (Cervical Cancer, Anal Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, and Others), By Distribution Channel (Hospitals & Clinics, Governmental & Non-Governmental Organizations, Public & Private Alliances, and Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview India Human Papillomavirus Vaccine Market was valued at USD 72.11 Million in 2024 and is expected to reach USD 102.10 Million by 2030, growing with a CAGR of 6.11% in the forecast peri...
September 2025
70 pages
Vaccine Delivery Devices Market 2026
US$ 2,999.00
The Vaccine Delivery Devices Market was valued at in and is anticipated to reach by , at a CAGR of 0.072 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
September 2025
219 pages
Vaccines Market - 2024-2032
US$ 2,999.00
The Vaccines Market was valued at US$ 77.01 billion in 2024 and is anticipated to reach US$ 108.82 billion by 2032, at a CAGR of 0.039 from 2026 to 2032. The report delivers in-depth insights into key...
September 2025
218 pages
Global Influenza Vaccine Market - 2024-2032
US$ 2,999.00
The Global Influenza Vaccine Market was valued at US$ 8.41 billion in 2024 and is anticipated to reach US$ 13.75 billion by 2032, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth ins...
September 2025
223 pages
Vaccine Adjuvants Market - 2024-2033
US$ 2,999.00
The Vaccine Adjuvants Market was valued at US$ 703.15 Million in 2024 and is anticipated to reach US$ 1,280.35 Million by 2033, at a CAGR of 0.069 from 2026 to 2032. The report delivers in-depth insig...
September 2025
210 pages
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
US$ 4,950.00
The vaccines market is expected to reach 63.66 billion USD in 2030, up from 50.46 billion USD in 2025, growing at a CAGR of 4.8% during the forecast period. Factors such as the high incidence of conta...
September 2025
450 pages
North America Therapeutic Vaccines Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
US$ 3,450.00
The North America therapeutic vaccines market is projected to grow significantly, reaching approximately USD 1,360,744.52 thousand by 2031, up from USD 565,764.46 thousand in 2024, reflecting a compou...
September 2025
121 pages
Hepatitis A Vaccine Market - 2024-2033
US$ 2,999.00
The Hepatitis A Vaccine Market was valued at USD 972.23 million in 2024 and is anticipated to reach USD 1325.05 million by 2033, at a CAGR of 0.035 from 2026 to 2032. The report delivers in-depth insi...
September 2025
243 pages
India Coronavirus Vaccine Market By Type (mRNA Based, Non-Replicating Viral Vector Based, Inactivated Vaccine), By Patient Type (Adult, Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview India Coronavirus Vaccine Market was values at USD 765.18 million in 2024 and is expected to USD 1259.90 Million by 2030, growing with a CAGR of 8.81% in the forecast period. A corona...
August 2025
82 pages
Global Personalized Cancer Vaccines Market - 2024-2033
US$ 2,999.00
The Global Personalized Cancer Vaccines Market was valued at US$ 11.33 Billion in 2024 and is anticipated to reach US$ 30.12 Billion by 2033, at a CAGR of 0.115 from 2026 to 2032. The report delivers...
August 2025
200 pages
mRNA Vaccine Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By mRNA Type (Nucleoside-modified mRNA, Unmodified mRNA, Self-Amplifying mRNA), By Application (COVID-19 mRNA Vaccines, Non COVID-19 mRNA Vaccines, Others), Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global mRNA Vaccine Market was valued at USD 11.45 billion in 2024 and is expected to reach USD 18.37 Billion by 2030 with a CAGR of 8.34% during the forecast period. The global mRNA...
August 2025
188 pages
Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication Type (Prostate Cancer, Melanoma, Bladder Cancer, Cervical Cancer), By Vaccine Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology Type (Recombinant Cancer Vaccines, Whole-Cell Cancer Vaccines, Viral Vector and DNA Cancer Vaccines), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Cancer Vaccine Market was valued at USD 8.32 billion in 2024 and is expected to reach USD 14.15 billion in the forecast period with a CAGR of 9.21% through 2030. A cancer vacci...
August 2025
187 pages
Global Influenza Vaccine Market: Analysis By Valency (Quadrivalent & Trivalent), By Vaccine Type (Inactivated And Live Attenuated), By Technology (Egg-based & Cell-based), By Age Group (Adult & Pediatric), By Route Of Administration (Injection & Nasal Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size and Trends with Forecast up to 2030
US$ 2,250.00
The influenza vaccine, often referred to as the flu vaccine, is a critical tool in the field of preventive medicine aimed at reducing the spread and impact of influenza, a contagious respiratory illne...
August 2025
165 pages
Inactivated Vaccines Market - 2024-2033
US$ 2,999.00
The Inactivated Vaccines Market was valued at US$ 22.60 billion in 2024 and is anticipated to reach US$ 34.26 billion by 2033, at a CAGR of 0.048 from 2026 to 2032. The report delivers in-depth insigh...
July 2025
218 pages
Ebola Virus Vaccine Market - 2024-2033
US$ 2,999.00
The Ebola Virus Vaccine Market was valued at US$ 173.82 million in 2024 and is anticipated to reach US$ 288.41 million by 2033, at a CAGR of 0.064 from 2026 to 2032. The report delivers in-depth insig...
July 2025
218 pages
Cancer Vaccines Market - 2023-2033
US$ 2,999.00
The Cancer Vaccines Market was valued at US$ 8.82 Billion in 2023 and is anticipated to reach US$ 14.96 Billion by 2033, at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth insights int...
July 2025
219 pages
Vaccines Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Type (Conjugated Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines), Indication (HPV, PCV, DTP, Hepatitis, Influenza, Dengue, and Others), Route of Administration (Injection, Oral, and Other), Age Group (Pediatric and Adult), and Geography
US$ 4,450.00
The vaccines market size is expected to grow from US$ 80.45 billion in 2024 to US$ 118.94 billion by 2031; it is projected to register a CAGR of 5.7% during 2025-2031. The growing incidences of infect...
July 2025
226 pages
Live Attenuated Vaccines Market - 2023-2033
US$ 2,999.00
The Live Attenuated Vaccines Market was valued at US$ 16.80 Billion in 2023 and is anticipated to reach US$ 31.56 Billion by 2033, at a CAGR of 0.066 from 2026 to 2032. The report delivers in-depth in...
June 2025
223 pages
Toxoid Vaccine Market - 2024-2033
US$ 2,999.00
The Toxoid Vaccine Market was valued at US$ 5,634.84 Million in 2024 and is anticipated to reach US$ 8,850.18 Million by 2033, at a CAGR of 0.058 from 2026 to 2032. The report delivers in-depth insigh...
June 2025
200 pages
Pediatric Vaccine Market - 2024-2033
US$ 2,999.00
The Pediatric Vaccine Market was valued at US$ 23.25 Billion in 2024 and is anticipated to reach US$ 38.53 Billion by 2033, at a CAGR of 0.058 from 2026 to 2032. The report delivers in-depth insights...
June 2025
220 pages
Shingles Vaccines Market 2026
US$ 2,999.00
The Shingles Vaccines Market was valued at in and is anticipated to reach by , at a CAGR of 0.1 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
June 2025
217 pages
Vaccine Storage and Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Vaccine Storage {Refrigerators, Freezers}, Vaccine Packaging {Cold Boxes, Vials & Ampoules, Corrugated Boxes, Bags, Others}), By Packaging Material (Plastic, Glass, Paper & Paperboard, Others), By End User (Pharma and Biotech Companies, Diagnostic Centers, Clinical Research Organization, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview The Global Vaccine Storage and Packaging Market was valued at USD 24.59 Billion in 2024 and is projected to reach USD 46.66 Billion by 2030, registering a CAGR of 11.24%. This market...
May 2025
183 pages
Global Adult Vaccine Market Size study, by Type (Influenza, Pneumococcal, Hepatitis, Zoster, Meningococcal, HPV, DTP, Others), Application (Infectious Diseases, Travel Vaccines, Health Maintenance), and Regional Forecasts 2022-2032
US$ 3,750.00
The Global Adult Vaccine Market is valued approximately at USD 20.51 billion in 2023 and is anticipated to grow with a steady yet compelling growth rate of more than 6.13% over the forecast period 202...
May 2025
285 pages
Global DTaP Vaccine Market - 2025-2033
US$ 4,350.00
Global DTaP Vaccine Market – Industry Trends & Outlook The global DTaP vaccine market reached US$ 5,378.83 Million in 2024 and is expected to reach US$ 11,592.17 Million by 2033, growing at a CAGR of...
May 2025
180 pages
Global MRNA Vaccines and Therapeutics Market - 2025-2033
US$ 4,350.00
Global MRNA Vaccines and Therapeutics Market Size - Industry Trends & Outlook The global MRNA Vaccines and Therapeutics market size reached US$ 410 Million in 2024 and is expected to reach US$ 850.90...
May 2025
168 pages
Global Travelers Vaccines Market - 2025-2033
US$ 4,350.00
Global Travelers Vaccines Market - Industry Outlook & Trends The global traveler's vaccines market reached US$ 4,092.58 million in 2024 and is expected to reach US$ 9,054.68 million by 2033, growing a...
May 2025
180 pages
